BCYC — BICYCLE THERAPEUTICS PLC

Ownership history in GSK plc  ·  1 quarter on record

This page tracks every 13F SEC filing in which GSK plc reported a position in BICYCLE THERAPEUTICS PLC (BCYC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.36% (2025 Q4)
Avg. % of fund
1.36%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 1,529,561 — — 1.36% $10.8M $7.08
% of Fund (quarterly)    BCYC price (monthly, adj. close)

Other funds also holding BCYC

As of 2025 Q4 — sorted by position size

FCPM III SERVICES B.V. 3.22% Birchview Capital, LP 3Y 7Y 1.92% FLAX POND CAPITAL, LLC 0.91% Rangeley Capital, LLC 0.78% BAKER BROS. ADVISORS LP 3Y 7Y 0.45% MONIMUS CAPITAL MANAGEMENT, LP 0.44% Nan Fung Group Holdings Ltd 3Y 0.44% Siren, L.L.C. 0.43% Long Focus Capital Management, LLC 3Y 0.3% PLATINUM INVESTMENT MANAGEMENT LTD 3Y 7Y 0.3%
← Back to GSK plc Holdings